Descriptor English: | Nabumetone | ||||||
Descriptor Spanish: |
Nabumetona
| ||||||
Descriptor Portuguese: | Nabumetona | ||||||
Descriptor French: | Nabumétone | ||||||
Entry term(s): |
4-(6-Methoxy-2-naphthyl)-2-butanone Apo-Nabumetone ApoNabumetone Arthraxan BRL 14777 Gen-Nabumetone Listran Mebutan Nabucox Nabumeton Relafen Relif Relifex Rhoxal nabumetone Rhoxal-nabumetone |
||||||
Tree number(s): |
D02.522.296.650 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077430 | ||||||
Scope note: | A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase 2 Inhibitors |
||||||
Registry Number: | LW0TIW155Z | ||||||
Public MeSH Note: | 2019; NABUMETONE was indexed under BUTANONES 1982-2018 |
||||||
History Note: | 2019 (1982) |
||||||
DeCS ID: | 57645 | ||||||
Unique ID: | D000077430 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/10 |
Nabumetone
- Preferred
Relifex
- Narrower
Relif
- Narrower
Apo-Nabumetone
- Narrower
Mebutan
- Narrower
Listran
- Narrower
Gen-Nabumetone
- Narrower
Arthraxan
- Narrower
BRL 14777
- Narrower
Rhoxal-nabumetone
- Narrower
Relafen
- Narrower
Nabucox
- Narrower
Concept UI |
M0109014 |
Scope note | A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS. |
Preferred term | Nabumetone |
Entry term(s) |
4-(6-Methoxy-2-naphthyl)-2-butanone Nabumeton |
Concept UI |
M0462770 |
Preferred term | Relifex |
Concept UI |
M0462771 |
Preferred term | Relif |
Concept UI |
M0462777 |
Preferred term | Apo-Nabumetone |
Entry term(s) |
ApoNabumetone |
Concept UI |
M000640745 |
Preferred term | Mebutan |
Concept UI |
M0462774 |
Preferred term | Listran |
Concept UI |
M0462775 |
Preferred term | Gen-Nabumetone |
Concept UI |
M0462776 |
Preferred term | Arthraxan |
Concept UI |
M0109012 |
Preferred term | BRL 14777 |
Concept UI |
M0462772 |
Preferred term | Rhoxal-nabumetone |
Entry term(s) |
Rhoxal nabumetone |
Concept UI |
M0109013 |
Preferred term | Relafen |
Concept UI |
M0462773 |
Preferred term | Nabucox |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey